Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

3.

Toll-like receptor family and signalling pathway.

Muzio M, Polentarutti N, Bosisio D, Manoj Kumar PP, Mantovani A.

Biochem Soc Trans. 2000 Oct;28(5):563-6. Review. Erratum in: Biochem Soc Trans 2001 Nov;29(Pt 6):869.

PMID:
11044375
4.

Toll receptors and pathogen resistance.

Takeda K, Akira S.

Cell Microbiol. 2003 Mar;5(3):143-53. Review.

PMID:
12614458
5.

Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responses.

Kirschning CJ, Bauer S.

Int J Med Microbiol. 2001 Sep;291(4):251-60. Review.

PMID:
11680785
6.

Toll-like receptors in inflammatory bowel diseases: a decade later.

Cario E.

Inflamm Bowel Dis. 2010 Sep;16(9):1583-97. doi: 10.1002/ibd.21282. Review.

7.

Recognition of fungal pathogens by Toll-like receptors.

Netea MG, Van der Graaf C, Van der Meer JW, Kullberg BJ.

Eur J Clin Microbiol Infect Dis. 2004 Sep;23(9):672-6. Epub 2004 Aug 18. Review.

PMID:
15322932
9.

The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function.

Sina C, Kemper C, Derer S.

Semin Immunol. 2018 Feb 24. pii: S1044-5323(17)30074-X. doi: 10.1016/j.smim.2018.02.008. [Epub ahead of print] Review.

PMID:
29486961
11.

Intestinal epithelial cell regulation of mucosal inflammation.

Yu Y, Sitaraman S, Gewirtz AT.

Immunol Res. 2004;29(1-3):55-68. Review.

PMID:
15181270
12.

Role of the innate immune system in the development of chronic colitis.

Kanai T, Ilyama R, Ishikura T, Uraushihara K, Totsuka T, Yamazaki M, Nakamuma T, Watanabe M.

J Gastroenterol. 2002 Nov;37 Suppl 14:38-42. Review.

PMID:
12572864
13.

Deregulation of intestinal anti-microbial defense by the dietary additive, maltodextrin.

Nickerson KP, Chanin R, McDonald C.

Gut Microbes. 2015;6(1):78-83. doi: 10.1080/19490976.2015.1005477. Review.

14.

Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease.

Guo BJ, Bian ZX, Qiu HC, Wang YT, Wang Y.

Ann N Y Acad Sci. 2017 Aug;1401(1):37-48. doi: 10.1111/nyas.13414. Review.

PMID:
28891095
15.

Interplay of Immunity and Vitamin D: Interactions and Implications with Current IBD Therapy.

Abdo J, Rai V, Agrawal DK.

Curr Med Chem. 2017;24(9):852-867. doi: 10.2174/0929867323666161026124951. Review.

PMID:
27784213
16.

Genetic factors associated with the development of inflammatory bowel disease.

Yamamoto-Furusho JK.

World J Gastroenterol. 2007 Nov 14;13(42):5594-7. Review.

17.

Role of toll-like receptors in inflammatory bowel disease.

Kordjazy N, Haj-Mirzaian A, Haj-Mirzaian A, Rohani MM, Gelfand EW, Rezaei N, Abdolghaffari AH.

Pharmacol Res. 2018 Mar;129:204-215. doi: 10.1016/j.phrs.2017.11.017. Epub 2017 Nov 16. Review.

PMID:
29155256
18.

Compartmentalizing intestinal epithelial cell toll-like receptors for immune surveillance.

Yu S, Gao N.

Cell Mol Life Sci. 2015 Sep;72(17):3343-53. doi: 10.1007/s00018-015-1931-1. Epub 2015 May 23. Review.

19.

Toll-like receptor activation by helminths or helminth products to alleviate inflammatory bowel disease.

Sun S, Wang X, Wu X, Zhao Y, Wang F, Liu X, Song Y, Wu Z, Liu M.

Parasit Vectors. 2011 Sep 27;4:186. doi: 10.1186/1756-3305-4-186. Review.

20.

Worms, flies and four-legged friends: the applicability of biological models to the understanding of intestinal inflammatory diseases.

Lin J, Hackam DJ.

Dis Model Mech. 2011 Jul;4(4):447-56. doi: 10.1242/dmm.007252. Epub 2011 Jun 13. Review.

Supplemental Content

Support Center